Masoud H. Manjili

Publications

• CD44(+)/CD24(-/low) Cancer Stem/progenitor Cells Are More Abundant in Triple-negative Invasive Breast Carcinoma Phenotype and Are Associated with Poor Outcome
  Human Pathology. Mar, 2012  |   Pubmed ID: 21835433
• A Signature of Immune Function Genes Associated with Recurrence-free Survival in Breast Cancer Patients
  Breast Cancer Research and Treatment. Feb, 2012  |   Pubmed ID: 21479927
• Suppression of Antigen-specific CD4(+) T Cell Activation by SRA/CD204 Through Reducing the Immunostimulatory Capability of Antigen-presenting Cell
  Journal of Molecular Medicine (Berlin, Germany). Nov, 2011  |   Pubmed ID: 22083206
• Favorable Outcomes in Patients with High Donor-Derived T Cell Count After In Vivo T Cell-Depleted Reduced-Intensity Allogeneic Stem Cell Transplantation
  Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Oct, 2011  |   Pubmed ID: 22005648
• Distinct Signatures of the Immune Responses in Low Risk Versus High Risk Neuroblastoma
  Journal of Translational Medicine. 2011  |   Pubmed ID: 21978632
• Targeting the Immunoregulator SRA/CD204 Potentiates Specific Dendritic Cell Vaccine-induced T-cell Response and Antitumor Immunity
  Cancer Research. Nov, 2011  |   Pubmed ID: 21914786
• An Immunologic Portrait of Cancer
  Journal of Translational Medicine. 2011  |   Pubmed ID: 21875439
• Activated NKT Cells and NK Cells Render T Cells Resistant to Myeloid-derived Suppressor Cells and Result in an Effective Adoptive Cellular Therapy Against Breast Cancer in the FVBN202 Transgenic Mouse
  Journal of Immunology (Baltimore, Md. : 1950). Jul, 2011  |   Pubmed ID: 21670315
• Prostate-derived Ets Transcription Factor (PDEF) is a Potential Prognostic Marker in Patients with Prostate Cancer
  The Prostate. Aug, 2011  |   Pubmed ID: 21656828
• Comment on "Cutting Edge: CD8+ T Cell Priming in the Absence of NK Cells Leads to Enhanced Memory Responses"
  Journal of Immunology (Baltimore, Md. : 1950). Jun, 2011  |   Pubmed ID: 21597038
• Revisiting Cancer Immunoediting by Understanding Cancer Immune Complexity
  The Journal of Pathology. May, 2011  |   Pubmed ID: 21480229
• Tumor Escape and Progression of HER-2/neu Negative Breast Cancer Under Immune Pressure
  Journal of Translational Medicine. 2011  |   Pubmed ID: 21453513
• Prostate-derived Ets Transcription Factor (PDEF) is a Potential Prognostic Marker in Patients with Prostate Cancer
  The Prostate. Jan, 2011  |   Pubmed ID: 21229552
• Adoptive Cell Therapy of Prostate Cancer Using Female Mice-derived T Cells That React with Prostate Antigens
  Cancer Immunology, Immunotherapy : CII. Mar, 2011  |   Pubmed ID: 21088965
• CD4+ T Cells Inhibit the Neu-specific CD8+ T-cell Exhaustion During the Priming Phase of Immune Responses Against Breast Cancer
  Breast Cancer Research and Treatment. Apr, 2011  |   Pubmed ID: 20480224
• Tumour Secreted Grp170 Chaperones Full-length Protein Substrates and Induces an Adaptive Anti-tumour Immune Response in Vivo
  International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2010  |   Pubmed ID: 20210603
• GM-CSF is One of the Main Breast Tumor-derived Soluble Factors Involved in the Differentiation of CD11b-Gr1- Bone Marrow Progenitor Cells into Myeloid-derived Suppressor Cells
  Breast Cancer Research and Treatment. Aug, 2010  |   Pubmed ID: 19898981
• IL-7 + IL-15 Are Superior to IL-2 for the Ex Vivo Expansion of 4T1 Mammary Carcinoma-specific T Cells with Greater Efficacy Against Tumors in Vivo
  Breast Cancer Research and Treatment. Jul, 2010  |   Pubmed ID: 19826947
• Human T Cells Express CD25 and Foxp3 Upon Activation and Exhibit Effector/memory Phenotypes Without Any Regulatory/suppressor Function
  Journal of Translational Medicine. 2009  |   Pubmed ID: 19849846
• Gemcitabine Directly Inhibits Myeloid Derived Suppressor Cells in BALB/c Mice Bearing 4T1 Mammary Carcinoma and Augments Expansion of T Cells from Tumor-bearing Mice
  International Immunopharmacology. Jul, 2009  |   Pubmed ID: 19336265
• Immune-induced Epithelial to Mesenchymal Transition in Vivo Generates Breast Cancer Stem Cells
  Cancer Research. Apr, 2009  |   Pubmed ID: 19276366
• Incubation of Antigen-sensitized T Lymphocytes Activated with Bryostatin 1 + Ionomycin in IL-7 + IL-15 Increases Yield of Cells Capable of Inducing Regression of Melanoma Metastases Compared to Culture in IL-2
  Cancer Immunology, Immunotherapy : CII. Oct, 2009  |   Pubmed ID: 19198835
• Adoptive Transfer of HER2/neu-specific T Cells Expanded with Alternating Gamma Chain Cytokines Mediate Tumor Regression when Combined with the Depletion of Myeloid-derived Suppressor Cells
  Cancer Immunology, Immunotherapy : CII. Jun, 2009  |   Pubmed ID: 18979098
• Radiofrequency Thermal Ablation of Breast Tumors Combined with Intralesional Administration of IL-7 and IL-15 Augments Anti-tumor Immune Responses and Inhibits Tumor Development and Metastasis
  Breast Cancer Research and Treatment. Apr, 2009  |   Pubmed ID: 18425677
• Prostate-derived Ets Transcription Factor As a Favorable Prognostic Marker in Ovarian Cancer Patients
  International Journal of Cancer. Journal International Du Cancer. Sep, 2008  |   Pubmed ID: 18567002
• Does HER-2/neu Antigen Loss in Metastatic Breast Tumors Occur Under Immune Pressure?
  International Journal of Cancer. Journal International Du Cancer. Sep, 2008  |   Pubmed ID: 18566999
• Signatures Associated with Rejection or Recurrence in HER-2/neu-positive Mammary Tumors
  Cancer Research. Apr, 2008  |   Pubmed ID: 18381452
• Danger Signals and Nonself Entity of Tumor Antigen Are Both Required for Eliciting Effective Immune Responses Against HER-2/neu Positive Mammary Carcinoma: Implications for Vaccine Design
  Cancer Immunology, Immunotherapy : CII. Sep, 2008  |   Pubmed ID: 18278493
• Tumor Immunoediting and Immunosculpting Pathways to Cancer Progression
  Seminars in Cancer Biology. Aug, 2007  |   Pubmed ID: 17662614
• Come Forth 1E10 Anti-idiotype Vaccine: Delivering the Promise to Immunotherapy of Small Cell Lung Cancer
  Cancer Biology & Therapy. Feb, 2007  |   Pubmed ID: 17426436
• HER-2/neu Antigen Loss and Relapse of Mammary Carcinoma Are Actively Induced by T Cell-mediated Anti-tumor Immune Responses
  European Journal of Immunology. Mar, 2007  |   Pubmed ID: 17304628
• Heat Shock Proteins As Vaccine Adjuvants in Infections and Cancer
  Drug Discovery Today. Jun, 2006  |   Pubmed ID: 16713905
• Comment on "Tumor Progression Can Occur Despite the Induction of Very High Levels of Self/tumor Antigen-specific CD8+ T Cells in Patients with Melanoma"
  Journal of Immunology (Baltimore, Md. : 1950). Apr, 2006  |   Pubmed ID: 16585536
• Immunoadjuvant Chaperone, GRP170, Induces 'danger Signals' Upon Interaction with Dendritic Cells
  Immunology and Cell Biology. Apr, 2006  |   Pubmed ID: 16519738
• Chaperoning Function of Stress Protein Grp170, a Member of the Hsp70 Superfamily, is Responsible for Its Immunoadjuvant Activity
  Cancer Research. Jan, 2006  |   Pubmed ID: 16424054
• Emergence of Immune Escape Variant of Mammary Tumors That Has Distinct Proteomic Profile and a Reduced Ability to Induce "danger Signals"
  Breast Cancer Research and Treatment. Apr, 2006  |   Pubmed ID: 16211331
• Heat Shock Proteins HSP70 and GP96: Structural Insights
  Cancer Immunology, Immunotherapy : CII. Mar, 2006  |   Pubmed ID: 16032399
• HSP110 Induces "danger Signals" Upon Interaction with Antigen Presenting Cells and Mouse Mammary Carcinoma
  Immunobiology. 2005  |   Pubmed ID: 16164037
• Heat Shock Proteins and Scavenger Receptors: Role in Adaptive Immune Responses
  Immunological Investigations. 2005  |   Pubmed ID: 16136784
• Cancer Immunotherapy and Heat-shock Proteins: Promises and Challenges
  Expert Opinion on Biological Therapy. Mar, 2004  |   Pubmed ID: 15006730
• Development of Cancer Vaccines Using Autologous and Recombinant High Molecular Weight Stress Proteins
  Methods (San Diego, Calif.). Jan, 2004  |   Pubmed ID: 14624871
• HSP110-HER2/neu Chaperone Complex Vaccine Induces Protective Immunity Against Spontaneous Mammary Tumors in HER-2/neu Transgenic Mice
  Journal of Immunology (Baltimore, Md. : 1950). Oct, 2003  |   Pubmed ID: 14530326
• Targeted Immunotherapy Using Reconstituted Chaperone Complexes of Heat Shock Protein 110 and Melanoma-associated Antigen Gp100
  Cancer Research. May, 2003  |   Pubmed ID: 12750279
• Hsp110 Over-expression Increases the Immunogenicity of the Murine CT26 Colon Tumor
  Cancer Immunology, Immunotherapy : CII. Aug, 2002  |   Pubmed ID: 12111119
• Development of a Recombinant HSP110-HER-2/neu Vaccine Using the Chaperoning Properties of HSP110
  Cancer Research. Mar, 2002  |   Pubmed ID: 11912148
• Immunotherapy of Cancer Using Heat Shock Proteins
  Frontiers in Bioscience : a Journal and Virtual Library. Jan, 2002  |   Pubmed ID: 11779704